ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669732 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669732; 2) Community: the network communities that were significantly associated with the response to NSC 669732; 3) Molecule: the relationships between components within communities and NSC 669732; 4) MDR: the compounds that were significantly associated with the NSC 669732.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0130238833303634 -0.17421134
NSC 725098 Null 0.0130238833303634 -0.084811018
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0130238833303634 0.48490873
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0130238833303634 0.33488612
NSC 752346 Null 0.0130238833303634 0.15433252
NSC 753661 methyl ester prodigiosene 0.0130238833303634 0.5429319
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0130238833303634 0.23646262
NSC 93819 Depakine 0.0130238833303634 0.13123731
NSC 268993 Deferoxamine hydrochloride 0.0152777849043083 0.1008958
NSC 671809 Null 0.0152777849043084 0.048687458
Total:133  Current:55    [First] [Prev] [Next] [Last]